We confirmed both in vitro and in vivo that YAP1/WWTR1/TEAD-dependent transcription is acutely activated following osimertinib treatment in EGFR mutant lung cancer and pharmacologic and genetic ablation of this complex strongly suppresses persister cells. The gene discussed is EGFR; the disease is lung cancer.